Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 6 of the 32 sources its claims cite were checked for support.
Abstract
BACKGROUND: Worldwide, adults and children are at risk of adrenal insufficiency as a result of adrenal suppression from use of anti-inflammatory glucocorticoids and opiates, as well as infectious diseases. The adrenocorticotropin (ACTH) stimulation test is the reference standard for diagnosis of adrenal insufficiency but requires clinic attendance and venesection. Salivary cortisone reflects free serum cortisol, and samples can be collected at home and posted to a laboratory. We tested whether home waking salivary cortisone level could be used to screen for adrenal insufficiency. METHODS: A prospective, diagnostic accuracy study was performed in patients at high risk of adrenal insufficiency. Patients collected a home salivary sample on waking and then attended the clinical facility for an ACTH stimulation test. Salivary cortisone was measured by liquid chromatography–tandem mass spectrometry. Receiver-operating characteristic curves were computed, and positive and negative predictive values were calculated. RESULTS: Two hundred twenty patients were recruited. As measured by an ACTH stimulation test, the prevalence of adrenal insufficiency was 44%. The area under the receiver-operating characteristic curve for waking salivary cortisone as a predictor of adrenal insufficiency was 0.95 (95% confidence interval [CI], 0.92 to 0.97). Cutoffs to ensure a minimum of 95% sensitivity and specificity gave a negative predictive value of 96% (95% CI, 90 to 99) and a positive predictive value of 95% (95% CI, 87 to 99) to exclude and confirm adrenal insufficiency, respectively. Waking salivary cortisone data provided information similar to that of an ACTH stimulation test in 70% of participants. Eighty-three percent of patients preferred home salivary collection to clinic attendance. CONCLUSIONS: Home waking salivary cortisone sampling has accuracy for the diagnosis of adrenal insufficiency similar to that of a standard ACTH stimulation test. Patients found the at-home test to be more convenient than the hospital-based test. (Funded by the National Institute for Health Research.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 0 Not valid · 14 Not checked · 71 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“diagnosis is often delayed [10][11][12][13]”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > Introduction A
What the sources say
- Not checked yetcites [10] matched to “Predisposing Factors for Adrenal Insufficiency” (2009) source
- Partly supportedcites [11] matched to “Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: a Danish population-based self-controlled case series analysis” (2019) sourceExperimental — accuracy not yet measured
The closest statement in our copy is in the Discussion (limitations paragraph): only 49 persons had a recorded diagnosis of treatment-induced adrenal insufficiency, and 'this small number most likely reflects lack of awareness and failure to diagnose iatrogenic adrenal insufficiency' — echoed in the Results ('Only 49 persons were coded with treatment-induced adrenal insufficiency during the observation period'). That supports under-recognition/non-diagnosis of glucocorticoid-induced (iatrogenic/tertiary) adrenal insufficiency in a Danish nationwide registry cohort, and it is hedged ('most likely reflects'). It does not state that diagnosis is 'often delayed' (a timing claim), nor does it address adrenal insufficiency in general or primary/secondary disease, which the citing sentence's unqualified wording carries. The Introduction's related framing is only that clinical implications rest on 'anecdotal reports' and that guidelines lack evidence-based recommendations [20, 21]. (LLM, conf=0.68)
- Not checked yetcites [12] matched to “High Incidence of Adrenal Crisis in Educated Patients With Chronic Adrenal Insufficiency: A Prospective Study” (2015) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“approximately 10% of patients taking opioids at a morphineequivalent dose of >20 mg/d are at risk of adrenal insufficiency.5”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > Introduction A
What the sources say
- Supportedcites [5] matched to “Prevalence of opioid-induced adrenal insufficiency in patients taking chronic opioids” (2020) source
The Discussion reports a 9% prevalence of opioid-induced adrenal insufficiency among patients taking chronic opioids for noncancer pain. The Adrenal function section says no patient taking less than 20 mg/day in morphine milligram equivalents developed it, and the Discussion recommends evaluation above 20 mg/day. Together, these support the approximate one-in-ten risk statement in the study’s chronic-pain context. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The standard test for adrenal insufficiency is the adrenocorticotropin (ACTH) stimulation test, also called the short Synacthen test.13,15,16”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > Introduction A
What the sources say
- Supportedcites [13] matched to “Diagnosis and management of adrenal insufficiency” (2015) source
The Diagnosis of Adrenal Insufficiency section (p. 8) identifies the ACTH stimulation test as the short Synacthen test and says it is commonly used to diagnose adrenal insufficiency. The same section says an ACTH stimulation test should be performed to establish the diagnosis safely, supporting its description as the standard test. (LLM, conf=0.93)
- Not checked yetcites [15] matched to “The short Synacthen test: a questionnaire survey of current usage” (2012) source
- Not checked yetcites [16] matched to “ACTH stimulation tests for the diagnosis of adrenal insufficiency: systematic review and meta-analysis” (2016) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Salivary cortisol is derived from serum-free cortisol, and late-night salivary cortisol is used in the diagnosis of Cushing's syndrome.22,23”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > Introduction A
What the sources say
- Supportedcites [22] matched to “The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.” (2008) source
Section 3.4.2 'Evidence for late-night salivary cortisol' states that 'Biologically active free cortisol in the blood is in equilibrium with cortisol in the saliva,' which supports the claim that salivary cortisol derives from serum-free cortisol. The same section, together with 3.4.2 Remarks, presents late-night salivary cortisol as a screening/diagnostic test for Cushing's syndrome (reference ranges at 2300-2400 h, loss of nadir in CS), so the second half of the sentence is also covered by this guideline. (LLM, conf=0.90)
- Not checked yetcites [23] matched to “Late-night salivary cortisol measurement in the diagnosis of Cushing’s syndrome” (2008) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A waking salivary cortisol cutoff value of 180 ng/dl (5 nmol/l) excluded adrenal insufficiency with a sensitivity of 95% (95% CI, 88 to 99) and an NPV of 94% (95% CI, 85 to 98);”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > SECONDARY MEASURES
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
36 more claims
Create a free account to see all 91 claims and to verify the 26 references still open.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 31
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A baseline serum cortisol < 152 nmol/L (< 5.5 μg/dL) confirmed glucocorticoid-induced adrenal insufficiency with a specificity of 97% and a positive predictive value of 95%.”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [55]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Debono et al found that a baseline serum cortisol >310 nmol/L (>11.2 μg/dL) measured by immunoassay excluded glucocorticoid-induced adrenal insufficiency with a sensitivity of 98% and a negative predictive value of 97% (data retrieved after contacting the authors) (55).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [55]
Experimental — accuracy not yet measuredIn the citing paper
“Morning salivary cortisol and cortisone are not expected to contribute significantly to CS diagnosis, but may be useful for screening of adrenal insufficiency [45].”
From Salivary cortisol and cortisone in diagnosis of Cushing's syndrome: a comparison of six different analytical methods (2023) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > Discussion
“Data from this test would have been sufficient to allow the provider to make an accurate diagnosis in 70% of individuals at risk of adrenal insufficiency.”
§ Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency > SECONDARY MEASURES
“The ACTH stimulation test would have been avoided in 70% (154 of 220) of participants -73 patients with waking salivary cortisone <251 ng/dl (7 nmol/l) and 81 patients with waking salivary cortisone 612 ng/dl (17 nmol/l).This two-stage process resulted in four patients who were falsely positive and three patients who were falsely negative (Table S2 and Table S3).”
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Self-citationBornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Diagnosis and management of adrenal insufficiency
Bancos, I., Hahner, S., Tomlinson, J., & Arlt, W. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70142-1 · Cited by 467
Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis
Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1218 · Cited by 456
Erichsen, M. M., Løvås, K., Skinningsrud, B., Wolff, A. B., Undlien, D. E., Svartberg, J., Fougner, K. J., Berg, T. J., Bollerslev, J., Mella, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1368 · Cited by 422
Prevalence of oral glucocorticoid usage in the United States: a general population perspective
Overman, R. A., Yeh, J., & Deal, C. L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21796 · Cited by 405
Hahner, S., Spinnler, C., Fassnacht, M., Burger-Stritt, S., Lang, K., Milovanovic, D., Beuschlein, F., Willenberg, H. S., Quinkler, M., & Allolio, B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3191 · Cited by 394
Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis
Kazlauskaite, R., Evans, A. T., Villabona, C. V., Abdu, T. A. M., Ambrosi, B., Atkinson, A. B., Choi, C. H., Clayton, R. N., Courtney, C. H., Gonc, E. N., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0710 · Cited by 385
Diagnosis of Adrenal Insufficiency
Dorin, R. I., Qualls, C. R., & Crapo, L. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-3-200308050-00009 · Cited by 374
Cited by
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae250 · Cited by 172
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L. T., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae029 · Cited by 156
Adrenal Insufficiency in Adults: A Review
Vaidya, A., Findling, J., & Bancos, I. (2025) · JAMA · doi:10.1001/jama.2025.5485 · Cited by 75
Diagnosis and management of adrenal insufficiency
Lewis, A., Thant, A. A., Aslam, A., Aung, P. P. M., & Azmi, S. (2023) · Clinical Medicine · doi:10.7861/clinmed.2023-0067 · Cited by 68
Iatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 40
“%) and <7 nmol/l predicted short synacthen test failure (specificity 97%), reducing the need for a short synacthen test by 70% 242,243 and was a superior predictor of short synacthen test results than morning serum cortisol levels.”
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status
Clarke, S. A., Eng, P. C., Comninos, A. N., Lazarus, K., Choudhury, S., Tsang, C., Meeran, K. M., Tan, T., Dhillo, W. S., & Abbara, A. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae016 · Cited by 38
Glucocorticoid treatment and adrenal suppression in children: current view and open issues
Improda, N., Chioma, L., Capalbo, D., Bizzarri, C., & Salerno, M. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02461-9 · Cited by 35
Ferrari, D., Bonaventura, I., Simeoli, C., Tomaselli, A., Vincenzi, L., De Alcubierre, D., Sciarra, F., Rizzo, F., Cerroni, L., Di Paola, N., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf206 · Cited by 28
Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome
Araujo-Castro, M., Lamas, C., Nowak, E., Newell-Price, J. D. C., Reincke, M., & Castinetti, F. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnaf042 · Cited by 24
Self-citationIssa, B. G., Hanna, F., Fryer, A. A., Ensah, G., Ebere, I., Marshall, D., & Keevil, B. G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad242 · Cited by 20
Self-citationReal world evidence supports waking salivary cortisone as a screening test for adrenal insufficiency
Debono, M., Caunt, S., Elder, C. J., Fearnside, J., Lewis, J., Keevil, B. G., Dixon, S., & Ross, R. J. M. (2023) · Clinical Endocrinology · doi:10.1111/cen.14975 · Cited by 21
“8 Bridging the gap between research and the clinic is important but not simple and it may take years to convince stakeholders and clinicians to change their clinical practise.”
BackgroundSelf-citationLanfermeijer, M., van Winden, L. J., Starreveld, D. E. J., Razab-Sekh, S., van Faassen, M. H. J. R., Bleiker, E. M. A., & van Rossum, H. H. (2024) · Analytical Biochemistry · doi:10.1016/j.ab.2024.115496 · Cited by 16
Bäcklund, N., Lundstedt, S., Tornevi, A., Wihlbäck, A.-C., Olsson, T., Dahlqvist, P., & Brattsand, G. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad763 · Cited by 13
“Interestingly, recent data also show good diagnostic properties for salivary cortisone sampling on awakening as a screening test for AI (45, 46).”
BackgroundUtility of Salivary Cortisol and Cortisone in the Diagnostics of Adrenal Insufficiency
Hellan, K. K., Lyngstad, M., Methlie, P., Løvås, K., Husebye, E. S., & Ueland, G. Å. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae486 · Cited by 13
Kervezee, L., Romijn, M., van de Weijer, K. N. G., Chen, B. S. J., Burchell, G. L., Tollenaar, M. S., Tamayo‐Ortiz, M., Philbrook, L. E., de Weerth, C., Cao, Y., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae590 · Cited by 13
“As such, our results strongly suggest that previously published cutoffs for the diagnosis of adrenal insufficiency in adults (75) cannot be automatically extrapolated to infants.”
Arshad, M. F., Elder, C., Newell-Price, J., Ross, R., & Debono, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae059 · Cited by 12
Self-citationTrandafir, A.-I., & Carşote, M. (2025) · Biomedicines · doi:10.3390/biomedicines13092169 · Cited by 11
“Salivary cortisone has been found as a better diagnosis test than salivary cortisol in adrenal insufficiency [65,66].”
Prete, A., Theiler‐Schwetz, V., Arlt, W., Hazeldine, J., Chifu, I.-O., Harbeck, B., Napier, C., Newell-Price, J. D. C., Rees, D. A., Reisch, N., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103714 · Cited by 11
“17 Salivary cortisone was chosen as it better reflects serum cortisol levels, 18 is not interfered with by oral hydrocortisone and can be measured when serum cortisol levels are low.”
Self-citationTan, S. Y. T., Tan, H. C., Zhu, L., Loh, L. M., Lim, D. S. T., Swee, D. S., Chan, Y. L., Lim, H. B., Ling, S. L., Ou, E. J., et al. (2023) · Endocrine Connections · doi:10.1530/ec-23-0004 · Cited by 10
Bäcklund, N., Brattsand, G., Lundstedt, S., Aardal, E., Bartuseviciene, I., Berinder, K., Höybye, C., Burman, P., Edén Engström, B., Isaksson, A., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0141 · Cited by 9
Diagnostic strategies in adrenal insufficiency
Siampanopoulou, V., Tasouli, E., & Angelousi, A. G. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000806 · Cited by 9
A New Approach — Home Waking Salivary Cortisone to Screen for Adrenal Insufficiency
Raff, H., & Zhang, C. D. (2023) · NEJM Evidence · doi:10.1056/evide2200306 · Cited by 8
Honour, J. W. (2024) · Steroids · doi:10.1016/j.steroids.2024.109502 · Cited by 7
Donald, D. M., McDonnell, T., O’Reilly, M., & Sherlock, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09897-7 · Cited by 8
“…effects of treatment inertia and manage risk factors appropriately, taking into account women with hypopituitarism’s elevated risk of cardiovascular disease. similar to that of the ACTH stimulation test and is unaffected by oral oestrogen as it measures free, rather than total cortisone [43].”
BackgroundMonitoring adrenal insufficiency through salivary steroids: a pilot study
Tucci, L., Fanelli, F., Improta, I., Bissi, V., Lena, C., Galante, G., Mezzullo, M., Magagnoli, M., Lalumera, A. B., Colombin, G., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae037 · Cited by 6
Optimizing diagnostic strategies for central adrenal insufficiency in pituitary disease
Haberbosch, L., Meyer, N. M. T., Lechner, L., Jensen, M., Soll, D., Kozarzewski, L., Hesse, L., Blankenstein, O., Hubertus, V., Vajkoczy, P., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf002 · Cited by 6
Diagnosis and management of secondary adrenal crisis
Martel‐Duguech, L., Poirier, J., Bourdeau, I., & Lacroix, A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09877-x · Cited by 8
“Recently, Debono et al. reported the accuracy of waking salivary cortisone to identify AI, including SAI, TAI and GIAI, as compared with the ACTH stimulation test [142].”
A practical approach to diagnosis and treatment in children with primary adrenal insufficiency
Capalbo, D., Illiano, S., Vasaturo, S., Lorello, P., Rotondo, F. R., Mase, R. D., Bizzarri, C., & Salerno, M. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf229 · Cited by 5
Clinical features, investigation, and management of Addison's disease
Dong, J., Hahner, S., Bancos, I., & Tomlinson, J. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00393-6 · Cited by 5
Lawrence, N., Arshad, M. F., Pofi, R., Ashby, S., Dawson, J., Tomlinson, J., Newell-Price, J. D. C., Ross, R. J. M., Elder, C. J., & Debono, M. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad127 · Cited by 5
“The validation dataset was collected after finalization of the prediction model, comprising new tests conducted between October 2021 and October 2022, after which local policy for repeat ASTs changed due to the employment of salivary cortisone testing to exclude AI [29].”
MethodSelf-citationGlucocorticoid prescribing in neurology
Jones, A. P., Debono, M., Walsh, J., Smith, C., Hunt, L., & McKevitt, F. M. (2024) · Practical Neurology · doi:10.1136/pn-2023-003855 · Cited by 5
Self-citationHeald, A. H., Mordaunt, M., Gallant, N., Baker, H., Majeed, W., Kochhar, R. S., Syed, A. A., Mudaliar, R. N., Abushufa, R., Hanna, F., et al. (2025) · Clinical Endocrinology · doi:10.1111/cen.15279 · Cited by 4
“The landmark Debono study analysis [9] of waking salivary cortisone provided information similar to that of a SST in 70% of participants.”
Self-citationTsiakas, S., Angelousi, A. G., Benetou, V., Orfanos, P., Xagas, E., Boletis, J., & Marinaki, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226712 · Cited by 5
“According to the authors, dynamic testing for diagnosing AI could be considered only for patients with persistent cortisol levels between 5.0 µ g/dL and 10.0 µ g/dL. Morning serum cortisol was evaluated as a diagnostic tool after validation with a dynamic 250 µ g ACTH test [40–42].”
InfluentialWäscher, H., Knauerhase, A., Klar, B., Postrach, T., Weber, M., & Willenberg, H. S. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2180-7108 · Cited by 5
“While the latter has a much lower concentration in plasma, the concentration of E is usually higher than F in urine or saliva because of which it may have been chosen for sensitivity and immunoassay calibration issues as a bi - omarker for AI during a recent study [20].”
BackgroundOrnetti, P., Bouillet, B., & Denimal, D. (2025) · RMD Open · doi:10.1136/rmdopen-2024-005251 · Cited by 4
“25 More recently, Eng et al reported that a baseline cortisol level >300 nmol/L (>10.9 µg/dL) predicted SST response with 93% sensitivity, while a base-line cortisol level 100 nmol/L ( 3.6 µg/dL) confirmed adrenal insufficiency with 97.3% specificity.”
InfluentialEvaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion
Law, C. C. Y., Sheskier, R., Viera, N., Delgado-Nieves, A., Seth, S., Hanžel, J., Ma, C., Colombel, J., Levine, A. C., Spencer, E. A., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf136 · Cited by 4
EndoCompass project: endocrine laboratory medicine
Heijboer, A. C., Hillebrand, J. J., Keevil, B. G., Ladang, A., Davies, E., Mertens, J., Özben, T., Stankovic, S. D., van Herwaarden, A. E., & Raverot, V. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf036 · Cited by 3
Self-citationSalivary Cortisone as a Potential Alternative to Cortisol in Periodontitis Severity Assessment
Dimitrov, D., Mlachkova, A., & Dosseva-Panova, V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020805 · Cited by 3
Lessons to learn from the 2024 NICE guideline on adrenal insufficiency
Dong, J., & Tomlinson, J. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00307-3 · Cited by 2
Saiegh, L., Dakwar, B., Jovanovic, K., Rosenblat, I., Mahamed, M., & Sheikh‐Ahmad, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1655146 · Cited by 2
EndoCompass Project: Endocrine Laboratory Medicine
Heijboer, A. C., Hillebrand, J. J., Keevil, B. G., Ladang, A., Davies, E., Mertens, J., Özben, T., Stankovic, S. D., van Herwaarden, A. E., & Raverot, V. (2025) · Hormone Research in Paediatrics · doi:10.1159/000549097 · Cited by 2
“One such initiative, which is bearing fruit, is the expanding use of salivary cortisone for the investigation of adrenal insufficiency [45, 46].”
Self-citationVoltan, G., Antonelli, G., Mondin, A., Tizianel, I., Sabbadin, C., Barbot, M., Basso, D., Scaroni, C. M., & Ceccato, F. (2023) · Endocrine · doi:10.1007/s12020-023-03597-z · Cited by 2
“Recently, in the diagnostic work-up of AI, high diagnostic accuracy of salivary waking cortisone (E) has been repor-ted, providing similar results to corticotropin stimulation test [11].”
ResultStress responses in blood donors: Oral fluid hormone dynamics and implications for donor support
Alterio, A., Feltracco, M., Mazzi, G., Rosso, B., Prosdocimi, L., & Gambaro, A. (2025) · Steroids · doi:10.1016/j.steroids.2025.109604 · Cited by 2
“Therefore, oral fluid sampling is favored because of its noninvasive nature, easy administration and quick performing, in contrast to blood sampling [17 – 19].”
Commentary: Cortisone or Cortisol, “the E” or “the F,” That Is the Question!
Ceccato, F., & Fleseriu, M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad348 · Cited by 3
Date, K. L., Baster, K., Caunt, S., Cohen, J., Debono, M., Fearnside, J., Johnson, T. N., Ross, R. J. M., Taylor, R. N., & Elder, C. J. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-094830 · Cited by 1
Self-citationNolan, J. D., Brown, S. J., Henley, D., & Lim, E. M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf424 · Cited by 1
Nervo, A., Gruosso, G., Marino, M., Migliore, E., Rubiolo, M., Vaccaro, E., & Arvat, E. (2025) · Clinical Endocrinology · doi:10.1111/cen.70023 · Cited by 1
Evidence-Based Uses of Salivary Cortisol Testing
Lucius, K. (2025) · Integrative and Complementary Therapies · doi:10.1089/ict.2025.81117.kl · Cited by 3
“35,36”
Fernández-Velasco, P., Asensio, L. E., Torres, B., Buigues, A. O., Hoyos, E. G., García, E. D., Román, D. A. D. L., & Díaz-Soto, G. (2026) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2025.501685 · Cited by 1
Rivière, É., Nunes, M. L., & Haissaguerre, M. (2024) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2024.10.001 · Cited by 1
Cortisone salivare al risveglio nella diagnosi dell’insufficienza surrenalica
Torchio, M., Scaroni, C. M., & Ceccato, F. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01282-x
“Il recente studio di accuratezza diagnostica condotto dall’Università di Sheffield in collaborazione con il Sheffield Teaching Hospitals NHS Foundation Trust [2] ha valutato l’accuratezza del cortisone salivare domiciliare al risveglio nella diagnosi di AI.”
BackgroundHypothalamic–pituitary–adrenal suppression
Kelsall, A., & Newell-Price, J. D. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00139-4
Self-citationDiagnosing adrenal insufficiency—something to spit at!
Mott, T. F., Echols, B., & McLemore, J. (2024) · Evidence-Based Practice · doi:10.1097/ebp.0000000000002311
Challenges of diagnosing and managing Addison’s disease in a resource-limited setting
Mwakyula, I. H., Kishimbo, P., Nzota, M., & Nsojo, A. A. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-259945
Almazrouei, R. A., Alshamsi, J., Abdelsalhen, M., Alkaabi, F., & Agha, A. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251335180
“14 Our results, incorporating the Abbott and Roche II assays, are in line with the previous studies; a baseline morning cortisol level of ⩾ 332 nmol/L corresponds to adequate adrenal reserve and obviates the need for ACTH stimulation.”
Diagnostic strategies for central adrenal insufficiency in clinical practice: authors’ response
Haberbosch, L., Strasburger, C. J., Maurer, L., & Mai, K. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf126
Abklärung bei adrenaler Insuffizienz: SOP Metyrapon-Test (Einmaldosis)
Baumgartner, C., & Wolf, P. S. (2025) · Journal für Endokrinologie Diabetologie und Stoffwechsel · doi:10.1007/s41969-025-00277-3
Adult Adrenal Insufficiency—Reply
Vaidya, A., Findling, J. W., & Bancos, I. (2025) · JAMA · doi:10.1001/jama.2025.14163
Ødum, S.-L. F., Grønborg, S. W., Main, K. M., & Klose, M. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf237
“Recent data support the high sensitivity and specificity of early morning salivary cortisol for ruling out adrenal insufficiency, with a cutoff well below the salivary cortisol of 38 nmol/L observed in our patient [21].”
Fernández-Velasco, P., Miralles, I. A., Lanchas, S. R., Torres, B., Buigues, A. O., Hoyos, E. G., Trapiello, W., Nieves, D. C., de Luis, D. A., & Díaz-Soto, G. (2025) · Endocrine · doi:10.1007/s12020-025-04455-w
Diagnostic performance of morning serum cortisol for glucocorticoid weaning in children and adults
Arshad, M. F., Ahmed, A., Beddows, S., Marsh, I., Mullamitha, A., Newell-Price, J. D. C., Ross, R. J. M., Elder, C. J., & Debono, M. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf215
Self-citationFernández-Velasco, P., Asensio, L., Torres, B., Buigues, A. O., Hoyos, E. G., García, E. D., Román, D. D. L., & Díaz-Soto, G. (2025) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2025.501685
Date, K. L., Baster, K., Caunt, S., Cohen, J., Debono, M., Fearnside, J., Johnson, T. N., Laud, P., Ross, R. J. M., Taylor, R. N., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-112708
“9 A recent NICE evidence review recommended further research on the clinical and cost-effectiveness of salivary cortisone/cortisol for AI diagnosis.”
Self-citationAdrenal insufficiency: Etiology and diagnosis
Nicolaides, N. C., & Charmandari, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00338-1
Adrenal Insufficiency in Adults
Abraham, S. B. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2025.12.001
Alenezi, G. E. K., Alqahtani, N., & Alsabaan, F. (2026) · Journal of Clinical Practice and Medical Research · doi:10.59324/jcpmr.2026.2(3).02
Delsinne, V., Kemlin, D., Driessens, N., & Moine, A. L. (2026) · Research Connections · doi:10.1093/rescon/vmag140
Ahmadian, S., Torres, C. A. V., Aggarwal, E., Moehnke, K. L., Fell, V. M., Peersen, A. F., Atkinson, E. J., Maus, A. D., & Bancos, I. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag393
Televantos, C., Monaghan, P. J., Michaelidou, M., Chen, L. R., Ahmed, M., Ho, J. H., Dhage, S. S., Higham, C., Keevil, B. G., & Adam, S. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag401
Self-citation
Metadata
- Authors
- Debono, M., Elder, C. J., Lewis, J., Fearnside, J., Caunt, S., Dixon, S., Jacques, R. M., Newell-Price, J., Whitaker, M. J., Keevil, B., & Ross, R. J.
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Sheffield (GB)
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- Ross, Richard J.
- ORCID
- Venue
- NEJM Evidence
- Publisher
- Massachusetts Medical Society
- Published
- 2023-01-24
- Volume
- 2
- Issue
- 2
- Pages
- EVIDoa2200182-EVIDoa2200182
- ISSN
- 2766-5526 (ISSN-L)
- OpenAlex
- W4313650042
- Semantic Scholar
- 41e470bb5f396fb14a33abbc635c0ffef42d8d13
- Cited by
- 66
- References
- 32
- Citations by year
- 2026: 8 · 2025: 25 · 2024: 21 · 2023: 12
- FWCI
- 13.57
- Type
- journal article
- Language
- en
- Open access
- Locations
- NEJM Evidence (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Funders
- National Institute for Health and Care Research (PB-PG-1217-20007, CL-2015-04-002)
- Academy of Medical Sciences (SGL015\1007)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- adrenal insufficiency, salivary cortisone, home sampling, ACTH stimulation test, diagnostic accuracy, free cortisol, glucocorticoid-induced adrenal suppression, patient preferences
- MeSH terms
- Adrenal Insufficiency, Cortisone, Humans, Hydrocortisone, Prospective Studies, Saliva
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.